GLIDAPA 3D 10/100/500 SR

Managing type 2 diabetes mellitus often requires a combination of medications that target different aspects of blood sugar regulation. GLIDAPA 3D 10/100/500 SR is a triple-combination prescription medicine containing 10 mg of Dapagliflozin, 100 mg of Sitagliptin, and 500 mg of Metformin SR. This advanced formulation is designed to help improve glycemic control in adults whose blood sugar levels are not adequately managed with diet, exercise, or single-drug therapy.

Manufactured and marketed by Steris Healthcare Pvt. Ltd., GLIDAPA 3D 10/100/500 SR is produced in a WHO-GMP-certified manufacturing facility, ensuring high standards of quality, safety, and consistency. It is available as an enteric-coated delayed-release tablet in a strip of 15 tablets and should only be used under the supervision of a qualified healthcare professional.

If you are looking to buy Dapagliflozin 10 mg, Sitagliptin 100 mg & Metformin SR 500 mg tablets online, GLIDAPA 3D 10/100/500 SR offers a comprehensive treatment option for adults with type 2 diabetes as part of an individualized diabetes management plan.

What is dapagliflozin, sitagliptin, and metformin?

GLIDAPA 3D 10/100/500 SR is a triple-combination oral antidiabetic medicine formulated for adults with type 2 diabetes mellitus. It combines three complementary medicines that work through different mechanisms to improve blood glucose control:

• Dapagliflozin 10 mg helps remove excess glucose through urine by inhibiting the SGLT2 protein in the kidneys.
• Sitagliptin 100 mg enhances the body's natural incretin hormones, helping increase insulin release after meals and reducing glucose production by the liver.
• Metformin SR 500 mg decreases glucose production in the liver, improves insulin sensitivity, and reduces intestinal glucose absorption. The sustained-release (SR) formulation helps provide gradual drug release and may improve gastrointestinal tolerability for some patients.

This combination supports comprehensive blood sugar management when used alongside a healthy diet, regular physical activity, and ongoing medical care.

Uses of Dapagliflozin 10 mg, Sitagliptin 100 mg & Metformin SR 500 mg

GLIDAPA 3D 10/100/500 SR may be prescribed for the following:

• Management of type 2 diabetes mellitus
• Improving long-term blood glucose control
• Lowering HbA1c levels
• Adults requiring triple-drug oral therapy
• Use along with diet and exercise
• Supporting comprehensive diabetes management under physician supervision

Note: This medicine is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

How do dapagliflozin, sitagliptin, and metformin work?

The three active ingredients work together to help regulate blood sugar through complementary pathways.

Dapagliflozin blocks SGLT2 proteins in the kidneys, allowing excess glucose to be excreted through urine rather than being reabsorbed into the bloodstream.

Sitagliptin is a DPP-4 inhibitor that increases incretin hormone activity. These hormones help the pancreas release insulin in response to meals while reducing excess glucose production by the liver.

Metformin SR reduces glucose production by the liver, improves the body's response to insulin, and lowers glucose absorption from the digestive tract. Its sustained-release formulation provides gradual medication release throughout the day.

Together, these mechanisms help achieve better blood sugar control than a single medicine alone in appropriately selected patients.

Benefits of dapagliflozin, sitagliptin, and metformin

When used as prescribed, GLIDAPA 3D 10/100/500 SR may offer several benefits:

• Helps lower fasting and post-meal blood glucose levels
• Supports improved HbA1c control
• Combines three proven antidiabetic medicines in one tablet
• May reduce the number of tablets required each day
• Sustained-release Metformin provides gradual medication release
• Can support long-term diabetes management alongside lifestyle changes
• Manufactured in a WHO-GMP-certified facility
• Convenient strip pack of 15 tablets

Dosage and Administration

Take GLIDAPA 3D 10/100/500 SR exactly as prescribed by your health care provider.

General recommendations include:

• Swallow the tablet whole with water.
• Do not crush, chew, or split the enteric-coated sustained-release tablet.
• Take the medicine at the same time each day, preferably with food if advised by your doctor.
• Continue following your recommended diabetic diet and exercise program.
• Monitor your blood sugar levels regularly according to your healthcare provider's instructions.

Never adjust the dose or discontinue treatment without consulting your physician.

Possible Side Effects

Like all medicines, GLIDAPA 3D 10/100/500 SR may cause side effects, although not everyone experiences them.

Common side effects include:

• Frequent urination
• Increased thirst
• Mild stomach discomfort
• Nausea
• Diarrhea
• Headache
• Nasal congestion
• Urinary tract infections
• Genital fungal infections
• Low blood sugar, particularly when used with insulin or sulfonylureas

Seek immediate medical attention if you experience symptoms of severe allergic reactions, persistent vomiting, severe dehydration, breathing difficulty, severe abdominal pain, or symptoms suggestive of lactic acidosis.

Precautions and Warnings

Before taking GLIDAPA 3D 10/100/500 SR, inform your doctor if you have:

• Kidney disease
• Liver disease
• Heart disease
• History of pancreatitis
• Frequent urinary tract infections
• Severe dehydration
• Metabolic acidosis
• History of diabetic ketoacidosis
• Alcohol dependence
• Allergy to Dapagliflozin, Sitagliptin, Metformin, or any tablet ingredients

Pregnant or breastfeeding women should use this medicine only if specifically recommended by their healthcare provider. Regular monitoring of kidney function and blood glucose may be advised during treatment.

Drug Interactions

Tell your doctor about all medicines, vitamins, and herbal supplements you are taking. Possible interactions include:

• Insulin
• Sulfonylureas
• Diuretics (water tablets)
• ACE inhibitors
• Corticosteroids
• Rifampicin
• Digoxin
• Carbonic anhydrase inhibitors
• Certain contrast dyes used for imaging procedures

Your doctor may recommend dosage adjustments or additional monitoring based on your overall treatment plan.

Storage Instructions

Store GLIDAPA 3D 10/100/500 SR:

• Below 30°C
• In a cool, dry place
• Away from moisture and direct sunlight
• In the original packaging
• Out of reach of children and pets

Do not use the medicine beyond its expiry date.

Why choose dapagliflozin, sitagliptin, and metformin?

GLIDAPA 3D 10/100/500 SR combines Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin SR 500 mg in a single tablet, offering a convenient option for adults who require combination therapy for type 2 diabetes. Manufactured by Steris Healthcare Pvt. Ltd. in a WHO-GMP-certified facility, the product is designed to meet stringent quality standards. When used as prescribed and paired with healthy lifestyle habits, it can support comprehensive blood sugar management and simplify medication routines for eligible patients.

Frequently Asked Questions 

1. What is dapagliflozin, sitagliptin, and metformin used for?

GLIDAPA 3D 10/100/500 SR is prescribed to help improve blood sugar control in adults with type 2 diabetes mellitus when diet, exercise, and other treatments alone are not sufficient.

2. How do Dapagliflozin, Sitagliptin, and Metformin work together?

Dapagliflozin removes excess glucose through urine, sitagliptin enhances insulin release and reduces glucose production after meals, and metformin decreases glucose production in the liver while improving insulin sensitivity.

3. Can dapagliflozin, sitagliptin, and metformin be used for type 1 diabetes?

No. This medicine is intended for adults with type 2 diabetes mellitus and is not approved for the treatment of type 1 diabetes or diabetic ketoacidosis.

4. Should I take dapagliflozin, sitagliptin, and metformin with food?

Your doctor may recommend taking it with food to improve gastrointestinal tolerance, particularly because it contains Metformin SR. Always follow your prescribed dosing instructions.

5. What are the common side effects of dapagliflozin, sitagliptin, and metformin?

Common side effects may include increased urination, thirst, nausea, diarrhea, headache, urinary tract infections, and genital fungal infections. Consult your healthcare provider if side effects persist or worsen.

6. Can this medicine be taken with insulin?

It may be used alongside insulin in selected patients if prescribed by a healthcare professional. Additional monitoring may be required because the combination can increase the risk of low blood sugar.

7. How should I store dapagliflozin, sitagliptin, and metformin tablets?

Store the tablets below 30°C in a cool, dry place, away from direct sunlight and moisture. Keep them in their original packaging and out of the reach of children.

8. Do I need a prescription to buy dapagliflozin, sitagliptin, and metformin?

Yes. GLIDAPA 3D 10/100/500 SR is a prescription-only medicine and should only be used under the guidance of a qualified healthcare professional.

Product Specifications

Product Details	Information
Brand Name	GLIDAPA 3D 10/100/500 SR
Generic Name	Dapagliflozin 10 mg, Sitagliptin 100 mg & Metformin SR 500 mg
Dosage Form	Enteric-coated Delayed-Release Tablet
Strength	Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin SR 500 mg
Pack Size	Strip of 15 Tablets
Manufactured & Marketed By	Steris Healthcare Pvt. Ltd.
Quality Standard	WHO-GMP Certified
Prescription Status	Valid Prescription Required (Prescription Only)